- Inflammatory bowel disease (IBD) is a chronic disease, which is used to describe disorders that involve chronic inflammation of the digestive tract.
- Fecal and serologic biomarkers can be used in the diagnosis and management of inflammatory bowel disease (IBD). Fecal markers, such as calprotectin and lactoferrin have been studied for their ability to identify patients with IBD, assess disease activity, and predict relapse.
- High prevalence of IBD boosts the in-vitro inflammatory bowel disease diagnostic market. In Europe, it is estimated that around 2.5 to 3 million people are affected by inflammatory bowel disease per year.
In-vitro Inflammatory Bowel Disease Diagnostic: Market Drivers
- According to CDC data, in 2015, an estimated 1.3% of adults in the U.S., which is around 3 million reported being diagnosed with IBD, either Crohn’s disease or ulcerative colitis. Highest incidence and prevalence of IBD is observed in Scandinavia and the U.K. Incidence of Crohn’s disease in Europe ranges from 0.5 to 10.6 cases per 100,000 people per year, while incidence of ulcerative colitis ranges from 0.9 to 24.3 per 100,000 persons per year.
- According to IBD Support Australia Incorporated, around 61,000 people in Australia are affected by inflammatory bowel disease of which, around 28,000 people are affected by Crohn’s disease and 33,000 are affected by ulcerative colitis
Download Sample of This Strategic Report: https://www.sdki.us/sample-request-111364
Rise in Demand for Less-invasive, Resource-benefit, and Cost-effective Diagnostic Modalities
- Diagnostic and prognostic features of IBD are usually based on a combination of clinical, laboratory tests, radiology, endoscopy, and pathology aspects. Laboratory biomarkers are noninvasive or micro-invasive indices that are more rapid and cost less as compared to other techniques, thus relieving physiological and financial burden for patients. The use of biomarkers for diagnosis and management of IBD is still necessary. Descriptions of immunological pathway abnormalities in IBD improve assessment to identify the patient’s disease status, and relative risk of progression to complicated disease behaviors, and this information may ultimately influence therapeutic decisions.
- Hence, high availability, easy access, high awareness, and cost-effectiveness provide in-vitro inflammatory bowel disease diagnostic a cutting edge over other options
Market Segmentation: In-vitro Inflammatory Bowel Disease Diagnostic Market
- In terms of product, the global in-vitro inflammatory bowel disease diagnostic market has been divided into assays/biomarker and analyzers. The assays/biomarker segment has been further subdivided into calprotectin, lactoferrin, bile acids, h. pylori sa, pancreatic elastase, and others.
- Based on end user, the global in-vitro inflammatory bowel disease diagnostic market has been classified into diagnostic laboratories, hospitals, and research institutes
- Each of the segments has been analyzed in detail for in-vitro inflammatory bowel disease diagnostic market trends, recent trends & developments, drivers, restraints, opportunities, and useful insights. The in-vitro inflammatory bowel disease diagnostic market report provides current and future value (US$ Mn) for each of these segments for the period from 2022-2031, considering 2019 as the base year. The compound annual growth rate (% CAGR) has been provided for each segment and market from 2022-2031, along with market size estimations.
Regional Overview: In-vitro Inflammatory Bowel Disease Diagnostic Market
- In terms of region, the global in-vitro inflammatory bowel disease diagnostic market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The regions have been divided into major countries and sub-regions.
- High prevalence of diseases and well-established healthcare infrastructure that enables proper diagnosis of inflammatory bowel disease are responsible for high market share of the region. According to a paper published in Gastroenterology & Hepatology journal, in 2017, there were 6.8 million cases of inflammatory bowel disease globally, and the highest prevalence rate in 2017 occurred in high-income North America.
- The current and future market sizes in terms of value (US$ Mn) of these regional markets and major countries have been provided in the report for the period from 2018 to 2030, along with their CAGRs for the period from 2020 to 2030
- The study also offers a list of recommendations, highlights, and useful insights of the market, which will help new companies willing to enter the market and existing companies to increase market share and in the decision-making process
Major Players
- The report concludes with the company profiles section that includes key information about the major players in the in-vitro inflammatory bowel disease diagnostic market
- Leading players analyzed in the report are
- DiaSorin S.p.A
- F. Hoffmann-La Roche Ltd
- Siemens Healthineers AG
- Abbott
- Quidel Corporation
- American Laboratory Products Company (ALPCO)
- Certest Biotec SL.
- Biosystems S.A.
- Each of these players has been profiled in the report based on parameters such as company overview, financial overview, business strategies, product portfolio, business segments, and recent developments
In-vitro Inflammatory Bowel Disease Diagnostic Market – Scope of the Report
The report on the global in-vitro inflammatory bowel disease diagnostic market studies the past as well as the current growth trends and opportunities to gain valuable insights of these indicators for the market during the forecast period from 2020 to 2030. The report provides the revenue of the global in-vitro inflammatory bowel disease diagnostic market for the period 2018–2030, considering 2019 as the base year and 2030 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global in-vitro inflammatory bowel disease diagnostic market from 2020 to 2030.
The report has been prepared after extensive research. Primary research involved bulk of research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the global in-vitro inflammatory bowel disease diagnostic market.
Download Sample of This Strategic Report: https://www.sdki.us/sample-request-111364
Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts have employed a combination of top-down and bottom-up approaches to study various attributes of the global in-vitro inflammatory bowel disease diagnostic market.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments and sub-segments included in the scope of the study. Moreover, the report sheds light on changing competitive dynamics in the global in-vitro inflammatory bowel disease diagnostic market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global in-vitro inflammatory bowel disease diagnostic market.
The report also delves into the competition landscape of the global in-vitro inflammatory bowel disease diagnostic market. Key players operating in the global in-vitro inflammatory bowel disease diagnostic market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global in-vitro inflammatory bowel disease diagnostic market that have been profiled in this report.
For more information about this report visit: In-vitro Inflammatory Bowel Disease Diagnostic Market
Key Questions Answered in In-vitro Inflammatory Bowel Disease Diagnostic Market Report
- What is the sales/revenue generated by in-vitro inflammatory bowel disease diagnostic products across all regions during the forecast period?
- What are the opportunities in the global in-vitro inflammatory bowel disease diagnostic market?
- What are the major drivers, restraints, opportunities, and threats in the global market?
- Which region is set to expand at the fastest CAGR during the forecast period?
- Which product segment is expected to generate the highest revenue globally in 2030? Which segment is projected to expand at the highest CAGR during the forecast period?
- What are the market positions of different companies operating in the global market?
In-vitro Inflammatory Bowel Disease Diagnostic Market – Research Objectives and Research Approach
The comprehensive report on the global in-vitro inflammatory bowel disease diagnostic market begins with an overview, followed by the scope and objectives of the study. Following this, the report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.
For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller sections. The report comprises an exhaustive collection of graphs and tables that have been appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of market shares of key segments in the past and at the end of the forecast period.
America Air Traffic Management Market
Middle-East and Africa Freighter Aircraft Market
Middle-East and Africa Helicopters Market
Europe Tactical UAV Market
Asia-Pacific Turboprop Aircraft Market
Close-in Weapon Systems Market
Asia-Pacific Freighter Aircraft Market
Asia-Pacific Light and Very Light Jets Market
Pressure Gauge Market
Explosive Ordnance Disposal Market
